BroadcomvsNutex Health

AVGO and NUTX stock compared: price, dividend, valuation and results, from SEC filings.

AVGO

Broadcom Inc.

$339.90

Value $1.61T

+1.94%
AVGO's page

NUTX

Nutex Health Inc.

$171.88

Value $1.2B

+1.28%
NUTX's page

Broadcom (AVGO) has a market value of $1.61T and Nutex Health (NUTX) $1.2B. Over the last year, with dividends, AVGO moved -0.1% and NUTX +60.5%. The P/E is 42.1 for AVGO and 7.3 for NUTX. Dividend yield: AVGO 0.76%, NUTX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AVGO$1.61T

    NUTX$1.2B

    AVGO is 1,346 times NUTX

  • Revenue, 12 months

    AVGO$89.1B

    NUTX$797M

    AVGO is 112 times NUTX

  • Net income, 12 months

    AVGO$38.3B

    NUTX$165M

    AVGO is 232 times NUTX

  • Operating margin

    AVGO48.1%

    NUTX39.0%

    9.1 points apart

  • ROIC

    AVGO27.3%

    NUTX61.1%

    33.8 points apart

  • P/E

    AVGO42.1

    NUTX7.3

    AVGO is 5.8 times NUTX

  • Dividend yield

    AVGO0.8%

    NUTX0.0%

    0.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AVGO+258.8%

NUTX+393.1%

0200400600202420252026
Returns by period
PeriodAVGOWith dividendsNUTXWith dividends
1 year since November 14, 2025-0.1%Price -0.8%+60.5%Price +60.5%
3 years since November 17, 2023+258.9%+53.1% a yearPrice +247.5%+396.0%+70.5% a yearPrice +396.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AVGOBroadcomNUTXNutex Health

Valuation

AVGONUTX
Valuation
Price$339.90$171.88
Market value$1.61T$1.2B
Enterprise value (EV)$1.65T$1.3B
P/E42.17.3
P/E, 5-year median30.4–
P/B16.22.8
EV/EBIT38.54.1
Free cash flow yield2.5%20.7%

Results and growth

AVGONUTX
Results and growth
Revenue, 12 months$89.1B$797M
Net income, 12 months$38.3B$165M
Free cash flow, 12 months$39.4B$248M
Earnings per share, 12 months$7.84$23.22
Revenue growth, year on year23.9%82.4%
Revenue growth a year, past+21.7%over 5 years+26.1%over 5 years
EPS growth a year, past+49.8%over 5 years-17.2%over 5 years

Margins and returns on capital

AVGONUTX
Margins and returns on capital
Gross margin68.8%47.8%
Operating margin48.1%39.0%
Net margin42.9%20.7%
ROIC27.3%61.1%
ROE45.4%45.2%

Balance sheet

AVGONUTX
Balance sheet
Cash$24.0B$250M
Total debt$59.4B$365M
Net debt / EBITDA0.80.3
Interest cover13.7×16.2×

Dividends and buybacks

AVGONUTX
Dividends and buybacks
Dividend yield0.8%–
Dividend per share, 12 months$2.60–
Dividend growth a year, past+12.7%over 5 years–
Buyback yield0.2%0.4%
Shareholder yield0.9%0.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AVGO or NUTX

Didn't find what you were looking for?

Ask us
Which is bigger, Broadcom or Nutex Health?

By market value, Broadcom ($1.61T) is about 1,345.5 times Nutex Health ($1.2B), at today's prices.

How did AVGO and NUTX stock do over the last 3 years?

Since November 17, 2023, AVGO's price moved +247.5% and NUTX's +396.0%. With dividends: AVGO +258.9% (+53.1% a year), NUTX +396.0% (+70.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, AVGO or NUTX?

The dividend yield at today's price is 0.76% for Broadcom and none for Nutex Health. Over the last twelve months they paid $2.60 and – per share.

What is the P/E of AVGO and NUTX?

At today's price, the P/E is 42.1 for AVGO and 7.3 for NUTX. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Broadcom or Nutex Health?

Over the last twelve months, the net margin was 42.9% for Broadcom and 20.7% for Nutex Health, and the operating margin 48.1% and 39.0%. Revenue was $89.1B and $797M.

Which is the better investment, Broadcom or Nutex Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.